Cargando…

Impact of the Obesity Paradox Between Sexes on In‐Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study

BACKGROUND: Several studies have shown that obesity is associated with better outcomes in patients with cardiogenic shock (CS). Although this phenomenon, the “obesity paradox,” reportedly manifests differently based on sex in other disease entities, it has not yet been investigated in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Woochan, Lee, Seung Hun, Yang, Jeong Hoon, Choi, Ki Hong, Park, Taek Kyu, Lee, Joo Myung, Song, Young Bin, Hahn, Joo‐Yong, Choi, Seung‐Hyuk, Ahn, Chul‐Min, Ko, Young‐Guk, Yu, Cheol Woong, Jang, Woo Jin, Kim, Hyun‐Joong, Kwon, Sung Uk, Jeong, Jin‐Ok, Park, Sang‐Don, Cho, Sungsoo, Bae, Jang‐Whan, Gwon, Hyeon‐Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238714/ https://www.ncbi.nlm.nih.gov/pubmed/35658518 http://dx.doi.org/10.1161/JAHA.121.024143

Ejemplares similares

Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock
por: Park, Ik Hyun, et al.
Publicado: (2023)

Culprit‐Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial‐Extracorporeal Membrane Oxygenation
por: Choi, Ki Hong, et al.
Publicado: (2023)

Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock
por: Jeong, Joo Hee, et al.
Publicado: (2023)

Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation
por: Kim, Mijoo, et al.
Publicado: (2022)

Clinical significance of lactate clearance in patients with cardiogenic shock: results from the RESCUE registry
por: Park, Ik Hyun, et al.
Publicado: (2021)

Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock
por: Park, Taek Kyu, et al.
Publicado: (2014)

Clinical Outcomes of Patients with Acute Myocardial Infarction Complicated by Severe Refractory Cardiogenic Shock Assisted with Percutaneous Cardiopulmonary Support
por: Park, Taek Kyu, et al.
Publicado: (2014)

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock
por: Na, Soo Jin, et al.
Publicado: (2022)

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017)

The Proximal Optimization Technique Improves Clinical Outcomes When Treated without Kissing Ballooning in Patients with a Bifurcation Lesion
por: Yang, Jeong Hoon, et al.
Publicado: (2019)

Comparison of in‐hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno‐arterial‐extracorporeal membrane oxygenation
por: Seong, Seok‐Woo, et al.
Publicado: (2021)

Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock
por: Yang, Jeong Hoon, et al.
Publicado: (2013)

Clinical Implications of Thrombocytopenia at Cardiogenic Shock Presentation: Data from a Multicenter Registry
por: Lee, Hyeok-Hee, et al.
Publicado: (2020)

Comparison of Exercise Performance and Clinical Outcome Between Functional Complete and Incomplete Revascularization
por: Kim, Jihoon, et al.
Publicado: (2020)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
por: Lee, Joo Myung, et al.
Publicado: (2019)

Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2020)

Comparison of long-term cardiovascular and renal outcomes between percutaneous coronary intervention and coronary artery bypass grafting in multi-vessel disease with chronic kidney disease
por: Kwon, Woochan, et al.
Publicado: (2022)

Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10‐Year Follow‐Up Study
por: Park, Taek Kyu, et al.
Publicado: (2021)

Use of intravascular ultrasound and long-term cardiac death or myocardial infarction in patients receiving current generation drug-eluting stents
por: Lee, Sang Yoon, et al.
Publicado: (2022)

Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test
por: Kim, Jihoon, et al.
Publicado: (2019)

P2Y(12) inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
por: Roh, Ji Woong, et al.
Publicado: (2021)

Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study
por: Kim, So Ree, et al.
Publicado: (2019)

Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era
por: Cho, Sung Woo, et al.
Publicado: (2020)

Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina
por: Gwag, Hye Bin, et al.
Publicado: (2017)

Spontaneous Closure of Iatrogenic Coronary Artery Fistula to Left Ventricle After Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
por: Choi, Yu Jeong, et al.
Publicado: (2006)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
por: Kim, Juwon, et al.
Publicado: (2018)

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Shin, Eun-Seok, et al.
Publicado: (2023)

Toxocariasis-Associated Acute Perimyocarditis with Cardiogenic Shock: A Case Report
por: Park, Se-Jin, et al.
Publicado: (2021)

Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
por: Kim, Dong-Yeon, et al.
Publicado: (2021)

Predictors of Cardiogenic and Non-Cardiogenic Causes in Cases with Bilateral Chest Infiltrates
por: Lee, Yeon Joo, et al.
Publicado: (2013)

Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study
por: Yang, Jeong Hoon, et al.
Publicado: (2014)

Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary Intervention
por: Hong, David, et al.
Publicado: (2022)

Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fraction
por: Seo, Jeong Hun, et al.
Publicado: (2022)

Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic function
por: Kook, Hyungdon, et al.
Publicado: (2020)

Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion
por: Hwang, Jin Kyung, et al.
Publicado: (2016)

Prognostic Value of Admission Blood Glucose Level in Critically Ill Patients Admitted to Cardiac Intensive Care Unit according to the Presence or Absence of Diabetes Mellitus
por: Kim, Sua, et al.
Publicado: (2019)

Mildly Elevated Cardiac Troponin below the 99th-Percentile Upper Reference Limit after Noncardiac Surgery
por: Park, Jungchan, et al.
Publicado: (2020)

Preoperative cardiac troponin below the 99th-percentile upper reference limit and 30-day mortality after noncardiac surgery
por: Park, Jungchan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9h6v9uobeppeto2pjkdi16jgou